Clear Street’s Cellyan Biotechnology HKPD Stock Holding History

Clear Street’s Portfolio HKPD Stock Details HKPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.57K	Hold	12,019	–	–	﹤0.01%	1270
2026 Q1	$6.83K	Hold	12,019	–	–	﹤0.01%	980
2025 Q4	$9.91K	Hold	12,019	–	–	﹤0.01%	788
2025 Q3	$17.7K	Hold	12,019	–	–	﹤0.01%	640
2025 Q2	$15.4K	Sell	12,019 -3,700	-24%	-$4.57K	﹤0.01%	475
2025 Q1	$17K	Buy	+15,719	New	+$27.8K	﹤0.01%	321

Other funds holding HKPD

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's HKPD Position: Q2 2026 in Review

Clear Street held its Cellyan Biotechnology (HKPD) position steady in Q2 2026 at 12,019 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Clear Street first reported a position in HKPD in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.7K in Q3 2025. 6 funds tracked by Wall St. Rank hold HKPD as of Q2 2026.

Clear Street held 12,019 shares of Cellyan Biotechnology worth $4.57K as of Q2 2026.
Clear Street left its Cellyan Biotechnology share count unchanged in Q2 2026.
Cellyan Biotechnology made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1270 holding.
Clear Street first reported a position in Cellyan Biotechnology in Q1 2025 and has held it in 6 quarters since.
Clear Street's Cellyan Biotechnology position peaked at $17.7K in Q3 2025.
6 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.